SCHEMBL6989136

SCHEMBL6989136

Clc1ccc(Cc2cc3ccc(Cl)cc3[nH]2)cc1

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
DAO P14920 3/20 0.49
LOXL2 Q9Y4K0 1/20 0.46
PCSK9 Q8NBP7 1/20 0.44
ALOX15 P16050 3/20 0.44
RHEB Q15382 1/20 0.43
DRD3 P35462 4/20 0.43
SIGMAR1 Q99720 4/20 0.43
DRD4 P21917 3/20 0.43
DRD5 P21918 1/20 0.43
KDM4C Q9H3R0 1/20 0.43
DRD1 P21728 2/20 0.42
TMEM97 Q5BJF2 2/20 0.42
F11 P03951 1/20 0.41
SIRT1 Q96EB6 1/20 0.41
CMA1 P23946 1/20 0.40
AHR P35869 1/20 0.40
CNR1 P21554 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6992345 0.90 SIGMAR1 (0.46) DAOLOXL2PCSK9ALOX15RHEB
SCHEMBL6993860 0.87 DAO (0.44) DAOLOXL2PCSK9ALOX15DRD3
SCHEMBL6826452 0.86 LOXL2 (0.64) DAOLOXL2PCSK9RHEBF11
SCHEMBL6619148 0.84 PCSK9 (0.57) DAOLOXL2PCSK9AHR
SCHEMBL7500914 0.83 DRD4 (0.44) DAORHEBDRD3SIGMAR1DRD4
SCHEMBL6989977 0.83 CYP1A2 (0.50) LOXL2ALOX15AHR
SCHEMBL4737672 0.79 HDAC8 (0.47) ALOX15KDM4C
SCHEMBL613213 0.78 RHEB (0.52) DAOLOXL2ALOX15RHEBF11
SCHEMBL13624442 0.78 ALOX15 (0.50) DAOLOXL2PCSK9ALOX15F11
SCHEMBL7490718 0.78 IMPDH2 (0.48) DAOLOXL2RHEB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1322646-A1 2-(1H-INDOL-3-YL)-2-OXO-ACETIC ACID AMIDES WITH ANTITUMOR ACTIVITY Novuspharma S.p.A. (IT) 2003-07-02 EP disclosed
WO-2002008225-A1 2-(1H-INDOL-3-YL)-2-OXO-ACETIC ACID AMIDES WITH ANTITUMOR ACTIVITY NOVUSPHARMA S.P.A. (IT) 2002-01-31 WO disclosed